Forte Paolo, Cattaneo Jennifer, Cardillo Piccolino Felice, Arrigo Alessandro, Corazza Paolo, Musetti Donatella, Rosa Raffaella, Traverso Carlo Enrico, Fontana Vincenzo, Lupidi Marco, Eandi Chiara Maria, Nicolò Massimo
Eye Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
DINOGMI, University of Genoa, Genoa, Italy.
Acta Ophthalmol. 2025 May;103(3):e165-e175. doi: 10.1111/aos.16779. Epub 2024 Oct 20.
To test the prognostic role of anterior scleral substantia propria (ASSP) thickness in predicting the 3-month response after half-dose photodynamic therapy (PDT) in central serous chorioretinopathy (CSCR) and to assess its clinical relevance of ASSP in different CSCR phenotypes.
A prospective, exploratory, multi-centre cohort study conducted at IRCCS San Martino Hospital (Genoa, Italy) and Jules-Gonin Eye Hospital (Lausanne, Switzerland). Demographic and clinical data, and optical coherence tomography (OCT) were collected at baseline and 3 months after PDT. Based on OCT images, we categorized CSCR phenotypes and collected clinically relevant imaging metrics. ASSP thickness was obtained from four different measurements using anterior segment (AS) OCT. Multivariable regression models were performed to evaluate the distribution of ASSP thicknesses among different CSCR phenotypes and to test the prognostic role of ASSP thickness in discriminating between PDT responders (complete subretinal fluid reabsorption) and partial responders.
The study cohort comprised 109 Caucasian patients (82 males, 75.2%) with a total of 142 eyes: 84 eyes simple (59.1%) versus 58 eyes complex (40.9%) CSCR. A linear normal model confirmed a positive association between complex CSCR and higher ASSP thickness (β = 26.1, 95% CL = 12.1/40.1, p < 0.001), with a low prevalence of ciliochoroidal effusion loculations in AS-OCT (1/142 eyes, 0.7%). ASSP thickening was positively linked to the presence of posterior cystoid retinal degeneration (PCRD; p = 0.002), indicating a potential role in the pathogenesis of severe CSCR phenotypes. In the subgroup of treated patients (61 eyes), 63.9% had a complete response after PDT. In these patients a logistic binary model highlighted a significantly higher risk of PDT non-responsiveness (OR = 9.62, 95% CL = 2.44/37.9, p = 0.001) associated with a 60-unit increase in ASSP thickness levels. By contrast, other anatomical parameters (i.e., body surface area, age, gender, axial length) showed no remarkable prognostic roles.
This research highlighted the association of ASSP thickening with complex CSCR phenotype in Caucasian patients and its role in predicting PDT efficacy. These findings enhance our comprehension of the anatomical risk factors in patients affected with CSCR and potentially guide a better understanding of non-responsive cases to PDT treatment.
检测中央性浆液性脉络膜视网膜病变(CSCR)患者半剂量光动力疗法(PDT)后3个月反应中前巩膜固有层(ASSP)厚度的预后作用,并评估ASSP在不同CSCR表型中的临床相关性。
在意大利热那亚的IRCCS圣马蒂诺医院和瑞士洛桑的朱尔斯-戈宁眼科医院进行了一项前瞻性、探索性、多中心队列研究。在基线和PDT后3个月收集人口统计学和临床数据以及光学相干断层扫描(OCT)。基于OCT图像,我们对CSCR表型进行分类并收集临床相关的成像指标。使用眼前节(AS)OCT通过四种不同测量获得ASSP厚度。进行多变量回归模型以评估不同CSCR表型之间ASSP厚度的分布,并测试ASSP厚度在区分PDT反应者(视网膜下液完全吸收)和部分反应者中的预后作用。
研究队列包括109名白种人患者(82名男性,75.2%),共142只眼:84只眼为单纯性(59.1%)CSCR,58只眼为复杂性(40.9%)CSCR。线性正态模型证实复杂性CSCR与较高的ASSP厚度之间存在正相关(β = 26.1,95%可信区间 = 12.1/40.1,p < 0.001),AS-OCT中睫状脉络膜积液小腔的患病率较低(1/142只眼,0.7%)。ASSP增厚与后部囊样视网膜变性(PCRD)的存在呈正相关(p = 0.002),表明其在严重CSCR表型的发病机制中可能起作用。在接受治疗的患者亚组(61只眼)中,63.9%在PDT后有完全反应。在这些患者中,逻辑二元模型突出显示与ASSP厚度水平增加60个单位相关的PDT无反应风险显著更高(OR = 9.62,95%可信区间 = 2.44/37.9,p = 0.001)。相比之下,其他解剖学参数(即体表面积、年龄、性别、眼轴长度)未显示出显著的预后作用。
本研究强调了白种人患者中ASSP增厚与复杂性CSCR表型的关联及其在预测PDT疗效中的作用。这些发现增强了我们对CSCR患者解剖学危险因素的理解,并可能有助于更好地理解对PDT治疗无反应的病例。